Benabou Kelly, Khadraoui Wafa, Khader Tarek, Hui Pei, Fernandez Rodrigo, Azodi Masoud, Menderes Gulden
Department of Obstetrics and Gynecology, Bridgeport Hospital/Yale New Haven Health, Bridgeport, CT, USA.
Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.
JSLS. 2021 Jan-Mar;25(1). doi: 10.4293/JSLS.2020.00081.
Minimally invasive oncologic surgery has become the standard of care in many gynecologic cancers. While laparoscopic surgery provides many benefits to patients, such as faster recovery, there are unique challenges associated with minimally invasive techniques. Port-site metastasis is a rare complication after laparoscopic oncologic surgery in management of gynecologic malignancies.
We present the case of a 44-year-old female with isolated port-site recurrence following laparoscopic radical hysterectomy with node-negative, clinical stage IB1 cervical adenocarcinoma. In addition, we provide an updated review of the literature on management and oncologic outcomes of port-site metastasis.
Port-site metastasis prevention necessitates a better understanding of underlying risk factors and pathophysiology in order to optimize outcomes. Future studies are needed on risk-reducing strategies and standardization of management for port-site metastasis.
微创肿瘤手术已成为许多妇科癌症的治疗标准。虽然腹腔镜手术给患者带来诸多益处，如恢复更快，但微创技术也存在独特挑战。切口种植转移是腹腔镜肿瘤手术治疗妇科恶性肿瘤后一种罕见的并发症。
我们报告了一例44岁女性患者，在腹腔镜根治性子宫切除术后出现孤立性切口复发，该患者为临床分期IB1期宫颈腺癌，淋巴结阴性。此外，我们还对切口种植转移的管理及肿瘤学结局的文献进行了更新综述。
预防切口种植转移需要更好地了解潜在危险因素和病理生理学，以优化治疗效果。未来需要开展关于降低风险策略及切口种植转移管理标准化的研究。
